Three-dimensional changes in lymphatic architecture around VX2 tongue cancer-dynamic changes after administration of antiangiogenic agent

Lymphology

Volumn 36, Issue 4, 2003, Pages 199-208

  Seki, Shotaro ^a   Fujimura, A ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; FUMAGILLOL CHLOROACETYLCARBAMATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD VESSEL DIAMETER; CANCER INVASION; CANCER TRANSPLANTATION; CAPILLARY FLOW; CELL INVASION; CERVICAL LYMPH NODE; CONTROLLED STUDY; DISEASE MODEL; GROWTH INHIBITION; HISTOPATHOLOGY; IMAGE RECONSTRUCTION; LYMPH FLOW; LYMPH NODE METASTASIS; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAINING; THREE DIMENSIONAL IMAGING; TONGUE CANCER; TUMOR GROWTH; VEIN BLOOD FLOW;

ANGIOGENESIS INHIBITORS; ANIMALS; CELL LINE, TUMOR; CYCLOHEXANES; DISEASE MODELS, ANIMAL; IMAGING, THREE-DIMENSIONAL; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHATIC SYSTEM; LYMPHATIC VESSELS; MALE; NEOPLASM TRANSPLANTATION; RABBITS; SESQUITERPENES; TONGUE NEOPLASMS;

EID: 0742283974     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Liotta, LA: Cancer cell invasion and metastasis. Sci. Am. 266 (1992), 34-42.
2. Honma, Y: A study on metastasis to the cervical lymph node of oral cancer. Jpn. J. Oral Maxillofac. Surg. 28 (1982), 1667-1684.
3. Fukuta, Y, Y Murakami, M Izumisawa, et al: Correlation between patterns of cervical lymph node metastasis and therapeutic outcome in oral squamous cell carcinoma. J. Jpn. Soc. Oral Tumor 9 (1997), 261-268.
4. Berger, G, K Javaherian, K-M Lo, et al: Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284 (1999), 808-812.
5. Folkman, J: What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82 (1990), 4-6.
6. Ohta, Y, Y Watanabe, T Tabata, et al: Inhibition of lymph node metastasis by antiangiogenic agent, TNP-470. Br. J. Cancer 75 (1997), 512-515.
7. Matsumoto, K, Y Ninomiya, M Inoue, et al: Intra-tumor injection of an angiogenesis inhibitor, TNP-470, in rabbits bearing VX2 carcinoma of the tongue. Int. J. Maxillofac. Surg. 28 (1999), 118-124.
8. Drevs, J, I Hofmann, H Hugenshmidt, et al: Effect of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model. Cancer Res. 60 (2000), 4819-4824.
9. Seki, S, A Fujimura: Three-dimensional changes in lymphatic architecture around VX2 tongue cancer. Dynamics in growth of cancer. Lymphology 36 (2003), 128-139.
10. Kurokawa, H, T Nakamura, T Murata, et al: An experimental study on cervical lymph node metastasis of VX2 tongue carcinoma. Jpn. J. Oral Maxillofac. Surg. 41 (1995), 751-758.
11. Ingber, D, T Fujita, S Kishimoto, et al: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348 (1990), 555-557.
12. Fujimura, A, S Seki, M-Y Leo, et al: Three-dimensional architecture of lymphatic vessels in tongue. Lymphology 36 (2003), 120-127.
13. Kawamoto, T, M Shimizu: A method for preparing 2- to 50-μm-thick fresh-frozen sections of large samples and undecalcified hard tissues. Histochem. Cell Biol. 113 (2000), 331-339.
14. Kato, S: Histochemical localization of 5'-nucleotidase in the lymphatic endothelium. Acta Histochem. Cytochem. 23 (1990), 613-620.
15. Pepper, MS: Lymphangiogenesis and tumor metastasis: more questions than answers. Lymphology 33 (2000), 144-147.
16. Kitadai, Y, T Amioka, K Haruma, et al: Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int. J. Cancer 93 (2001), 662-666.
17. Stacker, SA, C Caesar, ME Baldwin, et al: VEGF-D promotes the metastatic spread of tumor cell via the lymphatics. Nat. Med. 7 (2001), 186-191.
18. Yonemura, Y, Y Endo, H Fujita, et al: Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin. Cancer Res. 5 (1999), 1823-1829.
19. Kajita, T, Y Ota, K Kimura, et al: The expression of vascular endothelial growth factor C and its receptor in non-small cell lung cancer. Br. J. Cancer 85 (2001), 255-260.
20. Jain, RK, TP Padera: Prevention and treatment of lymphatic metastasis by antilymphangiogenic therapy. J. Nat. Cancer Inst. 94 (2002), 785-787.
21. Bergers, G, K Javaherian, K-M Lo, et al: Effect of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284 (1999), 808-812.
22. Carmeliet, P, RK Jain: Angiogenesis in cancer and other diseases. Nature 407 (2000), 249-257.
23. Beecken, W-D, CA Fernandez, AM Joussen, et al: Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice. J. Nat. Cancer Inst. 93 (2001), 382-387.
24. Kusaka, M, K Sudo, T Fujita, et al: Potent anti-angiogenic action of AGM-1470: Comparison to the fumagillin parent. Biochem. Biophys. Res. Commun. 174 (1991), 1070-1076.
25. 1 phase of the cell cycle. Cancer Res. 54 (1994), 2073-2076.
26. Toi, M, T Takayanagi, R Souma, et al: Inhibition of vascular endothelial cell growth factor induced cell growth by an angiogenesis inhibitor AGM-1470 in capillary endothelial cells. Oncol. Rep. 1 (1994), 423-426.